Author:
Chen Shanshan,Li Ping,Yang Rui,Cheng Ruirui,Zhang Furui,Wang Yuanyuan,Chen Xiaonan,Sun Qianqian,Zang Wenqiao,Du Yuwen,Zhao Guoqiang,Zhang Guojun
Funder
Major project of Ministry of Health of Henan
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference40 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
2. Nguyen KS, Neal JW, Wakelee H. Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol. 2014;5:576–87.
3. Habib S, Delourme J, Dhalluin X, Petyt G, Tacelli N, Scherpereel A, et al. Bevacizumab and weekly paclitaxel for non-squamous non-small cell lung cancer patients: a retrospective study. Lung Cancer. 2013;80:197–202.
4. Köhler J, Schuler M. Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a review. Onkologie. 2013;36:510–8.
5. Sgambato A, Casaluce F, Maione P, Rossi A, Ciardiello F, Gridelli C. Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown? J Thorac Dis. 2014;6:578–80.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献